EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

M1 Macrophage-Derived Extracellular Vesicles Enable Efficient Cytosolic Delivery of siRNA to Suppress Lung Squamous Cell Carcinoma

Huan Li, Yuanmei Lou, Jun Chen, Qichen Huang, Chaowu Liu, Zhijun Chen

ACS Applied Nano Materials · 13.11.2026 · 9 (45) · 21512-21522

DOI: 10.1021/acsanm.6c04434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Nano Materials, online erschienen am 03.11.2026. Verfasst von Huan Li und 5 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhoushan Medical and Health Science and Technology Plan, Medical Science and Technology Project of Zhejiang Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung squamous cell carcinoma (LUSC) remains a clinically challenging malignancy with limited targeted therapies. We previously reported Sugen kinase 495 (Sgk495) overexpression in LUSC and its pro-tumorigenic functions. However, efficient cytosolic delivery of Sgk495 siRNA to LUSC cells remains a major obstacle. Here, we engineered biomimetic nanoscale extracellular vesicles (EVs, ∼130 nm) derived from M1-polarized macrophages and loaded them with Sgk495 siRNA (M1 EV/siSgk495) as a targeted nanomedicine for LUSC therapy. Compared with M0 EVs and conventional liposomal nanocarriers, M1 EVs exhibited superior siRNA stability. Mechanistically, M1 EV/siSgk495 downregulated Sgk495, disrupted its interaction with E3 ligase COP1, reduced K48-linked polyubiquitination and proteasomal degradation of IFNGR1, and thereby upregulated IFNGR1 protein. Collectively, this M1 macrophage-derived EV nanoplatform inhibits LUSC via IFNGR1 stabilization, representing a promising biomimetic nanotherapeutic strategy for cytosolic RNAi-based treatment of LUSC.

Förderung

  • Zhoushan Medical and Health Science and Technology Plan
  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Li, H., Lou, Y., Chen, J., Huang, Q., Liu, C., & Chen, Z. (2026). M1 Macrophage-Derived Extracellular Vesicles Enable Efficient Cytosolic Delivery of siRNA to Suppress Lung Squamous Cell Carcinoma. ACS Applied Nano Materials, 9(45), 21512-21522. https://doi.org/10.1021/acsanm.6c04434

Vancouver

Li H, Lou Y, Chen J, Huang Q, Liu C, Chen Z. M1 Macrophage-Derived Extracellular Vesicles Enable Efficient Cytosolic Delivery of siRNA to Suppress Lung Squamous Cell Carcinoma. ACS Applied Nano Materials. 2026;9(45):21512-21522. doi:10.1021/acsanm.6c04434

BibTeX
@article{Li2026,
  author = {Li, Huan and Lou, Yuanmei and Chen, Jun and Huang, Qichen and Liu, Chaowu and Chen, Zhijun},
  title = {M1 Macrophage-Derived Extracellular Vesicles Enable Efficient Cytosolic Delivery of siRNA to Suppress Lung Squamous Cell Carcinoma},
  journal = {ACS Applied Nano Materials},
  year = {2026},
  volume = {9},
  number = {45},
  pages = {21512--21522},
  doi = {10.1021/acsanm.6c04434}
}
Kostenlos starten →